S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Axsome TherapeuticsIGM BiosciencesRocket PharmaceuticalsXencorTaro Pharmaceutical Industries
SymbolNASDAQ:AXSMNASDAQ:IGMSNASDAQ:RCKTNASDAQ:XNCRNYSE:TARO
Price Information
Current Price$67.36$87.43$55.58$49.27$71.50
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.41.51.61.01.1
Analysis Score3.41.42.51.32.5
Community Score2.72.62.93.12.2
Dividend Score0.00.00.00.00.0
Ownership Score0.83.32.50.00.0
Earnings & Valuation Score0.00.00.00.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$146.80$96.00$57.89$47.11$81.00
% Upside from Price Target117.93% upside9.80% upside4.15% upside-4.38% downside13.29% upside
Trade Information
Market Cap$2.52 billion$2.68 billion$3.07 billion$2.83 billion$2.74 billion
Beta2.59-1.122.050.80.92
Average Volume292,172174,618474,336228,59028,675
Sales & Book Value
Annual RevenueN/AN/AN/A$156.70 million$644.77 million
Price / SalesN/AN/AN/A18.074.24
CashflowN/AN/AN/A$0.63 per share$6.45 per share
Price / CashN/AN/AN/A77.8411.09
Book Value$5.18 per share$7.88 per share$6.10 per share$10.46 per share$55.15 per share
Price / BookN/AN/AN/A4.711.30
Profitability
Net Income$-68,350,000.00$-43,130,000.00$-77,270,000.00$26.88 million$244.24 million
EPS($2.01)($4.80)($1.58)$0.46$6.35
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A17.06
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-113.40%-45.94%
Return on Equity (ROE)-62.33%-33.30%-35.81%-13.56%10.36%
Return on Assets (ROA)-47.87%-30.28%-27.52%-12.03%8.38%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.36%N/A0.25%N/AN/A
Current Ratio9.99%13.90%7.30%9.08%2.53%
Quick Ratio9.99%13.90%7.30%9.08%2.25%
Ownership Information
Institutional Ownership Percentage63.64%47.60%N/AN/A11.23%
Insider Ownership Percentage26.00%79.34%41.40%3.66%13.80%
Miscellaneous
Employees53103841661,464
Shares Outstanding37.34 million30.70 million55.23 million57.46 million38.26 million
Next Earnings Date3/1/2021 (Confirmed)3/25/2021 (Estimated)5/5/2021 (Estimated)5/6/2021 (Estimated)5/18/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.